[68Ga]DOTA-IR-780-C-4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68Ga]DOTA-IR-780-C-4, covering 2025-09-09 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients [NA]